Drug Development Questions Dominate Hahn's Confirmation, Despite Talk About E-Cigs
Executive Summary
A plurality of the questions from the Senate HELP Committee at Stephen Hahn's confirmation hearing to head the US FDA focused on drug development issues, despite the time lawmakers spent discussing the agency's regulation of e-cigarettes.
You may also be interested in...
Questions To Califf In Second Confirmation Hearing Similar To Predecessors
However, the few Senate questions about industry ties, tobacco and food issues may surprise some observers.
Questions To Califf In Second Confirmation Hearing Similar To Predecessors
However, the few Senate questions about industry ties, tobacco and food issues may surprise some observers.
Califf Confirmation Hearing Round Two: Industry Ties Once Again May Bark Loud, Bite Lightly
The cardiologist seeking another term as FDA commissioner has been working in the pharma industry since leaving the post, but Senators have tended not to question nominee's work history extensively during previous confirmation hearings.